632 results on '"Pawlotsky, J."'
Search Results
2. PB0873 Small-Molecule Cyclophilin Inhibitors Potently Reduce Platelet Procoagulant Activity
3. Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon‐free direct‐acting antiviral combinations? Authors’ reply
4. Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor
5. Hepatitis C Virus Population Dynamics During Infection
6. First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022
7. Stratégies antivirales dans l’hépatite chronique C
8. First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022
9. IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C
10. Performance of rapid diagnostic tests for the detection of antibodies to hepatitis C virus in whole blood collected on dried blood spots
11. Update of the statements on biology and clinical impact of occult hepatitis B virus infection
12. Régulation de TMPRSS2 par la voie des androgènes et implications dans l’infection SARS-CoV-2
13. Association between IL28B polymorphism, TNFα and biomarkers of insulin resistance in chronic hepatitis C-related insulin resistance
14. Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care
15. Hepatitis C virus-induced activation of β-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events
16. EASL Recommendations on Treatment of Hepatitis C 2018
17. EASL recommendations on treatment of hepatitis C: Final update of the series☆
18. Microdiversity of Enterococcus faecalis isolates in cases of infective endocarditis: selection of non-synonymous mutations and large deletions is associated with phenotypic modifications
19. Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis
20. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. (Liver Disease)
21. Impact of smoking on histological liver lesions in chronic hepatitis C. (Liver Disease)
22. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C
23. Liver stiffness diminishes with antiviral response in chronic hepatitis C
24. Occupational transmission of hepatitis C virus resulting from use of the same supermarket meat slicer
25. Hepatitis C virus: from discovery to eradication in 40 years?
26. Diagnostic microbiologique pan-pathogène par métagénomique clinique, retour d’expérience en routine
27. Prediction of nonSVR to therapy with pegylated interferon-α2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment
28. Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase
29. Practical use of hepatitis C virus kinetics monitoring in the treatment of chronic hepatitis C
30. Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection
31. Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy
32. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study
33. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections
34. Hepatitis C virus replication kinetics in chimpanzees with self-limited and chronic infections
35. Decrease of the EBV viral load under antiviral treatment after allogeneic haematopoietic stem cell transplantation
36. Worsening of steatosis and fibrosis progression in hepatitis C
37. Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study
38. SHOULD THE PATIENTS WITH HISTOLOGICALLY MILD CHRONIC HEPATITIS C BE TREATED?
39. Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy
40. The non-structural 5A protein of hepatitis C virus
41. Hepatitis C virus (HCV) NS5A protein: role in HCV replication and resistance to interferon-α
42. Hepatitis C virus infection: virus/host interactions
43. GASTRIC MALT LYMPHOMA : A PATHOGENETIC ROLE OF HEPATITIS C VIRUS(HCV) ?
44. ALCOHOL INTAKE, EVEN MODERATE, INDUCES INCREASED HISTOLOGICAL ACTIVITY AND FIBROSIS IN PATIENTS WITH CHRONIC ACTIVE HEPATITIS C
45. ACKNOWLEDGEMENT OF REVIEWERS
46. C10/18 UTILITY OF HCV RNA LEVELS AT BASELINE AND EARLY IN TREATMENT TO PREDICT OUTCOME TO IFN THERAPY
47. C01/99 HEPATITIS C VIRUS (HCV) INFECTION AND SICKLE CELL DISEASE (SCD)
48. WP4/024 ROLE OF GBV-C/HGV INFECTION ON CHRONIC HEPATITIS C AND RESPONSE TO INTERFERON α THERAPY
49. GS1/006 RELATIONSHIP BETWEEN HCV GENETIC COMPLEXITY, EPIDEMIOLOGICAL, CLINICAL AND VIROLOGICAL CHARACTERISTICS OF HCV INFECTION AND RESPONSE TO INTERFERON α.
50. EASL Recommendations on Treatment of Hepatitis C 2015
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.